DexCom, Inc.

Informe acción NasdaqGS:DXCM

Capitalización de mercado: US$29.4b

DexCom Resultados de beneficios anteriores

Pasado controles de criterios 5/6

DexCom ha aumentado sus beneficios a una tasa media anual de 24.2%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 12% anual. Los ingresos han ido creciendo a una tasa media de 20.4% al año. La rentabilidad financiera de DexCom es de 34.4%, y sus márgenes netos son de 17.2%.

Información clave

24.2%

Tasa de crecimiento de los beneficios

23.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment 8.9%
Tasa de crecimiento de los ingresos20.4%
Rentabilidad financiera34.4%
Margen neto17.2%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Are Investors Undervaluing DexCom, Inc. (NASDAQ:DXCM) By 44%?

Nov 08
Are Investors Undervaluing DexCom, Inc. (NASDAQ:DXCM) By 44%?

DexCom Growing Into Its Valuation, But Still No Bargain

Oct 25

DexCom, Inc.'s (NASDAQ:DXCM) Price In Tune With Earnings

Oct 21
DexCom, Inc.'s (NASDAQ:DXCM) Price In Tune With Earnings

DexCom Q3 Preview: Walking On Eggshells With Its Channel Relationships

Oct 16

These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

Sep 30
These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

DexCom: Investors Discounting Long CGM Growth Runway

Sep 19

We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)

Sep 16
We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)

DexCom Q2 Earnings: Traditional Market Overreaction

Aug 07

Is Now The Time To Look At Buying DexCom, Inc. (NASDAQ:DXCM)?

Jul 26
Is Now The Time To Look At Buying DexCom, Inc. (NASDAQ:DXCM)?

DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures

Jul 26

Why Investors Shouldn't Be Surprised By DexCom, Inc.'s (NASDAQ:DXCM) P/E

Jul 12
Why Investors Shouldn't Be Surprised By DexCom, Inc.'s (NASDAQ:DXCM) P/E

DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact

Jul 03

DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

Jun 28
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Jun 03
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Dexcom: Positive Catalysts Ahead To Support Growth

May 13

If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity

May 07
If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity

DexCom: Attractive Discount After Strong Earnings Results

May 06

Returns At DexCom (NASDAQ:DXCM) Are On The Way Up

Apr 25
Returns At DexCom (NASDAQ:DXCM) Are On The Way Up

Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price

Apr 12
Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price

DexCom Is Pricey For A Reason - Its Growth Story Reflects That

Apr 11

Is DexCom (NASDAQ:DXCM) Using Too Much Debt?

Mar 29
Is DexCom (NASDAQ:DXCM) Using Too Much Debt?

Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Mar 04
Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

DexCom: A Wealth Compounder In Healthcare

Feb 14

DexCom: Stelo Stellar Outlook

Jan 17

DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital

Jan 15
DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital

DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing

Jan 01
DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing

DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

Dec 18
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Dec 05
A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?

Nov 21
At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?

DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital

Sep 28
DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital

DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Sep 13
DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Aug 29
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Aug 14
Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet

Jun 05
DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet

There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital

May 16
There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital

Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?

Mar 21
Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?

These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

Mar 03
These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price

Feb 13
DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price

Desglose de ingresos y gastos

Cómo gana y gasta dinero DexCom. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqGS:DXCM Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 243,9546811,262549
30 Jun 243,9356671,242545
31 Mar 243,8026391,208528
31 Dec 233,6225421,185506
30 Sep 233,4033771,187486
30 Jun 233,1983581,135465
31 Mar 233,0232931,085467
31 Dec 222,9103411,008484
30 Sep 222,793244936605
30 Jun 222,673230900623
31 Mar 222,572258837631
31 Dec 212,449217811604
30 Sep 212,319577749487
30 Jun 212,170562709445
31 Mar 212,027530660396
31 Dec 201,927550618360
30 Sep 201,821231574320
30 Jun 201,716205539299
31 Mar 201,601148541288
31 Dec 191,476101516274
30 Sep 191,351-171499252
30 Jun 191,222-170479236
31 Mar 191,128-130452214
31 Dec 181,032-127433417
30 Sep 1891543414191
30 Jun 18833-5393184
31 Mar 18761-33368182
31 Dec 17719-50349185
30 Sep 17669-48336180
30 Jun 17633-65327181
31 Mar 17599-88311172
31 Dec 16573-66286156
30 Sep 16533-57268141
30 Jun 16490-80245125
31 Mar 16445-64221113
31 Dec 15402-58198101
30 Sep 15356-5817394
30 Jun 15319-2015585
31 Mar 15285-2314076
31 Dec 14259-2212869
30 Sep 14227-2611660
30 Jun 14201-2710452
31 Mar 14178-319447
31 Dec 13160-308442

Ingresos de calidad: DXCM tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (17.2%) de DXCM son superiores a los del año pasado (11.1%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: DXCM ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 24.2% al año.

Acelerando crecimiento: El crecimiento de los beneficios de DXCM en el último año (80.6%) supera su media de 5 años (24.2% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de DXCM en el último año (80.6%) superó al de la industria Medical Equipment 10.4%.

Rentabilidad financiera

Alta ROE: Aunque la rentabilidad financiera (34.4%) de DXCM es alta, esta métrica está sesgada debido a su elevado nivel de endeudamiento.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y